Press Releases

Date	Title	Company
11-Jan-2022	Increase in incidence of hospital-acquired infections is enabling growth in the instrument cleaners and detergents market, which is expected to reach US$ 2.02 Bn in 2021. The market is projected to register growth at a positive pace between 2021 and 2031,:	MARKITWIRED
11-Jan-2022	Emesis Bags Market Share and Growth Factors Impact Analysis 2028	MARKITWIRED
11-Jan-2022	Takeda übernimmt Adaptate Biotherapeutics zur Entwicklung neuartiger Gamma-delta-(γδ)-T-Zell-Engager-Therapien gegen solide Tumore	Businesswire
11-Jan-2022	Central Patient Monitoring System Market Estimated to Expand at a Robust CAGR By 2028	MARKITWIRED
11-Jan-2022	Global revenue pool of biological & chemical indicators market will expand nearly 2X over forecast period, 2030-2030: FMI	MARKITWIRED
11-Jan-2022	Localized Temperature Therapy Products Market to rise at 6% CAGR between 2020 and 2030 : FMI	MARKITWIRED
11-Jan-2022	Intrauterine Insemination (IUI) Treatment Market Will Escalate Rapidly in the Near Future	MARKITWIRED
11-Jan-2022	Oral Anticoagulants Market : Key Players, Growth, Analysis, by 2028	MARKITWIRED
11-Jan-2022	Global foley catheters market is expected to surge past valuation of US$ 2.2 Bn by the end of 2030 : FMI	MARKITWIRED
11-Jan-2022	Robocath concludes first European clinical study to demonstrate safety and efficacy of robotic coronary angioplasty performed with R-One	Andrew Lloyd Associates
11-Jan-2022	Samenvatting: Toezichthouders keuren Impella 5.5 met SmartAssist goed in Japan en Hongkong; US FDA verleent voorwaardelijke IDE-goedkeuring voor Impella BTR voor eerste-humanstudie naar vroege haalbaarheid	Businesswire
11-Jan-2022	Riassunto: Approvata a livello normativo Impella 5.5 con SmartAssist in Giappone e a Hong Kong; la FDA statunitense concede a Impella BTR l'approvazione condizionale IDE per il primo studio di fattibilità precoce su soggetti umani	Businesswire
10-Jan-2022	Ocular Drug Delivery Technology Market Foreseen To Grow Exponentially Over 2022 – 2031	MARKITWIRED Latest Market Reports
10-Jan-2022	Riassunto: Takeda rileverà Adaptate Biotherapeutics per sviluppare nuove terapie basate su T-cell engager Gamma Delta (γδ) mirate ai tumori solidi	Businesswire
10-Jan-2022	ZIVO Bioscience Names Chairman John B. Payne as President and CEO	Businesswire
10-Jan-2022	Flow Cytometry Market To Witness An Outstanding Growth By 2022 – 2031	MARKITWIRED Latest Market Reports
10-Jan-2022	Labcorp to Announce Fourth Quarter and Full Year 2021 Financial Results on February 10, 2022	Businesswire
10-Jan-2022	Takeda Emphasizes Strategy for Delivering Sustainable Growth Over Next Decade at the 40th Annual J.P. Morgan Healthcare Conference	Businesswire
10-Jan-2022	Nashville Biosciences and Illumina Announce Agreement to Establish Preeminent Clinico-Genomic Resource for Life Sciences Research & Development	Businesswire
10-Jan-2022	Takeda en passe d'acquérir Adaptate Biotherapeutics pour développer de nouvelles thérapies associées aux engageurs de cellules T Gamma Delta (γδ) ciblant les tumeurs solides	Businesswire